论文部分内容阅读
目的评价稳心颗粒对老年心律失常的疗效及安全性。方法将入选病例随机分为稳心颗粒组(60例)和普罗帕酮组(60例),疗程均4周,观察用药前后临床症状、早搏次数及不良反应情况。结论稳心颗粒组与普罗帕酮组,总有效率无统计学差异,P<0.05。两组治疗前后血、尿常规、肝、肾功能及电解质水平均无明显变化。结论稳心颗粒对心律失常的疗效与普罗帕酮相似,并在临床症状的改善以及不良反应方面优于普罗帕酮。
Objective To evaluate the efficacy and safety of Wenxinkeli on senile arrythmias. Methods The selected patients were randomly divided into Wenxin Granule group (60 cases) and propafenone group (60 cases) for 4 weeks. The clinical symptoms, premature beat frequency and adverse reactions were observed before and after treatment. Conclusion There is no significant difference in the total effective rate between Wenshen granule group and propafenone group (P <0.05). Before and after treatment, blood, urine, liver and kidney function and electrolyte levels did not change significantly. Conclusion Wenxin Granule has a similar curative effect to propafenone on arrhythmia and is superior to propafenone in improving clinical symptoms and adverse reactions.